Replies to post #364782 on Innovation Pharmaceuticals Inc (IPIX)

[TradingPro]

The Merck antiviral seems to be in the lead . They have played to pay, look how fast they got to PHIII compared to B. Should be an interesting compare in data as both trial results will come out about the same timeframe. Hopefully their will be some funding left for IPIX after Merck, absconds with what’s available.

[sunspotter]

Interesting article. Thanks for posting it.

[Longpicker]

Nice article, I just don’t get the part (and I’ve seen this many times before) where it appears the author writes all about a drug with qualities of Brilacidin and its potential therapeutic properties but somehow it never came up in all of their “research” to write the article. Seems impossible. Why is IPIX and Brilacidin so far under the radar? Serious question.